Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000117900 | SCV000304419 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000288096 | SCV000470514 | benign | Peroxisome biogenesis disorder 1A (Zellweger) | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
SIB Swiss Institute of Bioinformatics | RCV000288096 | SCV000803438 | benign | Peroxisome biogenesis disorder 1A (Zellweger) | 2018-05-31 | criteria provided, single submitter | curation | This variant is interpreted as a Benign - Stand Alone, for Peroxisome biogenesis disorder 1A (Zellweger), in Autosomal Recessive manner. The following ACMG Tag(s) were applied: BP4 => Multiple lines of computational evidence suggest no impact on gene or gene product (conservation, evolutionary, splicing impact, etc.). BA1 => Allele frequency is >2% in Exome Aggregation Consortium (in some populations allele frequency is >4%). BS2 => Observed in a healthy adult individual for a recessive (homozygous), dominant (heterozygous), or X-linked (hemizygous) disorder, with full penetrance expected at an early age. |
Athena Diagnostics Inc | RCV000992519 | SCV001144899 | benign | not provided | 2018-11-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001513794 | SCV001721477 | benign | Zellweger spectrum disorders | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000288096 | SCV001748551 | benign | Peroxisome biogenesis disorder 1A (Zellweger) | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000992519 | SCV001829571 | likely benign | not provided | 2023-10-18 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Genetic Services Laboratory, |
RCV000117900 | SCV000152174 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Diagnostic Laboratory, |
RCV000117900 | SCV001742320 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000117900 | SCV001920834 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000992519 | SCV001928420 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001513794 | SCV002076877 | benign | Zellweger spectrum disorders | 2017-03-29 | no assertion criteria provided | clinical testing |